PPM1D and cyclic hematopoiesis: Notably, 9 patients had multiple mutations in PPM1D. Age (Fig. 1c), number of prior therapy lines (1 vs > 1 therapy line), and prior PARPi treatment were significantly associated with the presence of CH (Table 1).